Mesa Laboratories logo
Mesa Laboratories MLAB
$ 78.03 -0.73%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Mesa Laboratories Financial Ratios 2011-2025 | MLAB

Annual Financial Ratios Mesa Laboratories

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-283.1 -1.8 760.2 370.1 432.1 741.0 121.4 -214.2 46.0 32.5 31.2 32.8 19.6 20.6 16.0

P/S

2.3 2.2 3.2 3.8 10.6 8.5 8.8 6.6 5.5 4.3 4.2 5.6 3.6 4.1 3.0

EPS

-0.4 -47.2 0.2 0.4 0.7 0.4 1.9 -0.8 3.0 3.1 2.7 2.6 2.5 2.4 1.9

EV (Enterprise Value)

805 M 741 M 942 M 957 M 1.35 B 1.12 B 944 M 694 M 582 M 434 M 341 M 323 M 175 M 163 M 110 M

EBITDA per Share

4.01 -49.7 1.43 1.53 6.03 4.96 7.11 6.76 6.81 6.52 6.11 4.54 4.93 4.58 3.62

EV/EBITDA

44.8 50.8 33.8 26.5 22.5 17.1 15.0 19.6 10.0 10.4 8.7

PEG

0.38 0.0 -44.92 -23.47 8836.15 -8.86 0.35 1.7 -23.77 2.33 7.4 9.19 4.3 0.79 0.57

P/B

3.5 3.2 1.8 1.8 3.5 4.5 8.2 6.4 5.3 4.3 4.1 4.6 3.1 3.7 2.7

P/CF

11.9 10.6 25.3 17.7 38.2 39.9 31.0 28.8 -133.4 39.6 37.4 26.1 15.8 13.8 15.9

ROE %

-1.24 -174.87 0.24 0.48 0.81 0.61 6.72 -2.98 11.43 13.19 13.04 13.99 16.02 18.03 16.98

ROA %

-0.46 -56.90 0.14 0.26 0.54 0.32 4.77 -1.80 6.51 6.95 8.17 9.23 12.82 15.62 12.13

ROCE %

10.22 -187.13 0.84 1.19 3.04 1.99 13.41 10.90 10.51 11.93 15.45 13.50 21.39 27.62 24.03

Current Ratio

1.6 1.5 2.5 2.3 3.1 4.7 1.4 1.9 2.2 1.6 2.0 2.6 4.2 4.5 1.7

DSO

61.4 68.9 69.8 64.4 61.2 65.5 44.3 54.3 55.8 66.0 62.1 64.2 66.6 59.8 78.3

DIO

117.6 148.1 126.6 86.8 98.8 98.5 58.5 81.0 125.3 153.9 162.3 134.8 115.8 100.6 157.3

DPO

23.9 26.8 30.0 30.0 30.7 23.6 25.1 20.9 19.6 31.0 32.7 35.0 21.0 13.0 19.9

Operating Cycle

178.9 217.0 196.4 151.2 160.0 164.0 102.8 135.3 181.1 219.9 224.4 199.1 182.4 160.3 235.6

Cash Conversion Cycle

155.0 190.2 166.4 121.2 129.4 140.4 77.8 114.4 161.5 188.9 191.7 164.0 161.4 147.4 215.7

All numbers in USD currency

Quarterly Financial Ratios Mesa Laboratories

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.45 0.87 - -0.31 0.63 0.63 - 0.39 -0.23 -0.1 - 0.08 0.25 -0.27 - -0.39 0.7 1.1 0.76 -0.89 0.52 0.27 -0.37 -1.03 -1.03 0.76 1.18 0.22 0.22 0.26 1.12 -2.93 0.63 0.41 0.41 0.88 0.88 0.64 0.53 0.72 0.72 0.51 0.77 0.68 0.68 0.87 0.54 0.51 0.51 0.57 0.55 0.46 0.46 0.67 0.63 0.6 0.6 0.63 0.51

EBITDA per Share

1.1 0.82 - 1.26 0.93 1.29 - 0.19 0.16 0.05 - 1.98 2.09 0.67 4.67 0.65 3.94 3.12 2.17 0.75 0.88 1.65 - -0.74 0.94 2.17 1.94 0.91 2.2 1.57 - -2.67 0.97 1.14 - 1.19 4.79 3.01 - 1.06 4.36 2.81 - 1.05 4.5 3.05 - 0.82 3.24 2.11 - 0.73 3.51 2.51 - 0.96 3.29 2.16 -

ROE %

2.04 2.78 3.32 3.85 5.42 2.98 0.07 0.18 -0.23 0.44 0.09 -0.43 -1.07 -0.50 0.90 1.40 0.81 0.58 0.40 -0.80 -1.62 -4.22 -3.17 1.40 4.11 6.96 10.47 10.89 -1.65 -0.33 -3.72 -6.45 8.76 10.13 11.31 12.04 11.79 11.48 11.18 12.65 12.78 12.94 15.16 14.34 13.97 13.60 12.54 13.14 13.24 13.34 14.68 15.94 17.62 19.40 18.90 18.74 4.97 4.39 4.61

ROA %

0.89 1.07 1.14 1.42 2.09 1.15 0.01 0.07 -0.14 0.25 0.27 -0.02 -0.37 0.03 0.64 0.97 0.53 0.38 0.27 -0.44 -0.78 -2.38 -0.60 2.71 4.31 6.08 7.33 6.99 -0.16 0.57 -1.76 -3.47 5.04 5.64 6.20 6.52 6.29 6.00 6.10 7.25 7.64 8.12 9.33 8.92 8.73 9.24 9.50 9.47 10.01 9.75 10.10 12.33 13.86 15.40 15.25 14.43 3.93 3.22 3.32

ROCE %

11.65 11.18 9.49 9.47 5.84 3.65 -0.20 0.68 1.57 2.65 0.74 0.10 -1.41 -1.27 2.41 2.41 3.05 2.99 2.08 0.69 -0.69 -3.28 -0.84 3.69 6.30 8.97 8.05 -7.16 -19.07 -16.83 -5.25 -0.57 14.79 23.48 24.35 29.10 29.17 30.29 26.73 31.90 32.32 35.80 33.91 38.70 38.33 36.36 29.79 34.71 34.83 39.00 38.46 46.04 48.70 52.61 46.08 7.58 22.86 15.64 -

Current Ratio

1.7 1.7 1.6 1.6 1.6 1.5 1.5 2.2 2.5 2.5 2.5 2.4 2.3 - 2.3 2.2 2.9 2.9 3.1 3.0 3.0 3.0 2.2 2.2 2.4 3.9 3.5 3.1 3.0 2.9 2.5 2.3 2.5 2.5 2.3 2.2 2.2 2.2 2.1 2.1 2.0 2.9 2.7 2.6 2.6 2.5 2.9 2.7 7.1 6.8 7.4 4.7 4.0 3.2 7.5 5.9 - - 3.6

DSO

59.5 62.1 - 59.7 59.8 58.5 - 61.7 61.7 70.4 - 70.8 32.5 37.3 - 50.0 15.7 28.6 53.1 52.0 52.3 59.5 54.2 45.7 45.0 44.2 44.5 45.3 47.2 48.6 45.2 47.3 49.9 54.8 51.2 50.4 17.0 27.8 52.6 59.5 54.7 48.9 60.3 60.5 57.8 49.3 50.4 55.4 46.8 53.5 65.3 60.3 58.5 53.1 54.3 60.4 62.2 66.5 -

DIO

108.9 107.9 - 108.9 125.4 140.5 - 156.5 148.3 164.6 - 131.0 57.2 58.7 - 62.7 21.5 41.8 - 80.3 106.7 114.4 - 69.5 37.1 62.3 64.6 65.8 70.1 79.2 - 97.0 123.4 124.3 - 128.3 43.2 64.9 - 166.3 51.1 73.4 - 156.4 45.0 57.3 - 111.7 37.3 56.0 - - - - - 133.2 - - -

DPO

22.1 24.3 - 23.2 23.8 25.5 - 21.3 22.5 27.5 - 29.7 15.8 18.9 - 21.5 7.5 15.3 - 18.9 20.1 29.6 - 16.6 14.7 27.3 23.9 19.5 21.3 23.3 - 16.9 20.5 20.6 - 28.4 9.5 12.9 - 36.1 10.4 14.0 - 37.5 10.4 13.2 - 22.9 9.1 12.6 - - - - - 18.3 - - -

Operating Cycle

168.3 170.0 - 168.6 185.2 199.1 - 218.2 210.0 235.0 - 201.7 89.7 96.0 - 112.7 37.2 70.5 53.1 132.4 159.0 173.9 54.2 115.2 82.1 106.5 109.1 111.2 117.2 127.8 45.2 144.3 173.3 179.1 51.2 178.7 60.2 92.7 52.6 225.8 105.8 122.2 60.3 216.9 102.7 106.6 50.4 167.1 84.1 109.5 65.3 60.3 58.5 53.1 54.3 193.6 62.2 66.5 -

Cash Conversion Cycle

146.2 145.8 - 145.4 161.4 173.6 - 197.0 187.5 207.5 - 172.0 73.9 77.2 - 91.2 29.7 55.1 53.1 113.5 138.9 144.4 54.2 98.6 67.4 79.2 85.2 91.7 95.9 104.5 45.2 127.5 152.7 158.5 51.2 150.4 50.8 79.8 52.6 189.7 95.3 108.2 60.3 179.4 92.3 93.4 50.4 144.2 75.0 96.9 65.3 60.3 58.5 53.1 54.3 175.2 62.2 66.5 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Mesa Laboratories, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Scientific technical instruments industry

Issuer Price % 24h Market Cap Country
FLIR Systems, Inc. FLIR Systems, Inc.
FLIR
- - $ 7.56 B usaUSA
CyberOptics Corporation CyberOptics Corporation
CYBE
- - $ 401 M usaUSA
Electro-Sensors Electro-Sensors
ELSE
$ 4.55 - $ 15.6 M usaUSA
Genasys Genasys
GNSS
$ 2.11 -1.86 % $ 93.5 M usaUSA
Itron Itron
ITRI
$ 96.3 -2.0 % $ 4.37 B usaUSA
Bonso Electronics International Bonso Electronics International
BNSO
- -5.08 % $ 5.44 M chinaChina
Keysight Technologies Keysight Technologies
KEYS
$ 208.61 -2.58 % $ 36.3 B usaUSA
Image Sensing Systems, Inc. Image Sensing Systems, Inc.
ISNS
- 2.38 % $ 34.5 M usaUSA
MTS Systems Corporation MTS Systems Corporation
MTSC
- - $ 1.14 B usaUSA
MIND Technology MIND Technology
MIND
$ 8.51 -2.43 % $ 34.7 K usaUSA
Cognex Corporation Cognex Corporation
CGNX
$ 35.78 -3.0 % $ 6.13 B usaUSA
ESCO Technologies ESCO Technologies
ESE
$ 204.56 -0.96 % $ 5.28 B usaUSA
Fortive Corporation Fortive Corporation
FTV
$ 54.8 -1.19 % $ 19.1 B usaUSA
Garmin Ltd. Garmin Ltd.
GRMN
$ 208.38 -0.72 % $ 40 B schweizSchweiz
Novanta Novanta
NOVT
$ 118.31 -1.59 % $ 4.25 B usaUSA
MicroVision MicroVision
MVIS
$ 0.94 -3.98 % $ 172 M usaUSA
FARO Technologies FARO Technologies
FARO
- - $ 842 M usaUSA
Luna Innovations Incorporated Luna Innovations Incorporated
LUNA
- -58.85 % $ 27.4 M usaUSA
Trimble Trimble
TRMB
$ 80.72 -3.15 % $ 19.8 B usaUSA
MKS Instruments MKS Instruments
MKSI
$ 154.4 -7.44 % $ 10.4 B usaUSA
Vontier Corporation Vontier Corporation
VNT
$ 37.06 -0.27 % $ 5.66 B usaUSA
Schmitt Industries Schmitt Industries
SMIT
- 10.39 % $ 1.62 M usaUSA
Sensata Technologies Holding plc Sensata Technologies Holding plc
ST
$ 34.65 -3.75 % $ 5.21 B niderlandNiderland
Teledyne Technologies Incorporated Teledyne Technologies Incorporated
TDY
$ 517.43 -1.08 % $ 24.4 B usaUSA
Velodyne Lidar Velodyne Lidar
VLDR
- - $ 300 M usaUSA
Vishay Precision Group Vishay Precision Group
VPG
$ 38.15 -2.15 % $ 509 M usaUSA
Energous Corporation Energous Corporation
WATT
$ 5.31 -1.39 % $ 38 M usaUSA